H. Harputluoglu And K. Altundag, "How can we use anthracylines in the management of newly diagnosed metastatic breast cancer patients overexpressing HER-2?," ANNALS OF ONCOLOGY , vol.19, no.6, pp.1203, 2008
Harputluoglu, H. And Altundag, K. 2008. How can we use anthracylines in the management of newly diagnosed metastatic breast cancer patients overexpressing HER-2?. ANNALS OF ONCOLOGY , vol.19, no.6 , 1203.
Harputluoglu, H., & Altundag, K., (2008). How can we use anthracylines in the management of newly diagnosed metastatic breast cancer patients overexpressing HER-2?. ANNALS OF ONCOLOGY , vol.19, no.6, 1203.
Harputluoglu, H., And K. Altundag. "How can we use anthracylines in the management of newly diagnosed metastatic breast cancer patients overexpressing HER-2?," ANNALS OF ONCOLOGY , vol.19, no.6, 1203, 2008
Harputluoglu, H. And Altundag, K.. "How can we use anthracylines in the management of newly diagnosed metastatic breast cancer patients overexpressing HER-2?." ANNALS OF ONCOLOGY , vol.19, no.6, pp.1203, 2008
Harputluoglu, H. And Altundag, K. (2008) . "How can we use anthracylines in the management of newly diagnosed metastatic breast cancer patients overexpressing HER-2?." ANNALS OF ONCOLOGY , vol.19, no.6, p.1203.
@article{article, author={H. Harputluoglu And author={K. Altundag}, title={How can we use anthracylines in the management of newly diagnosed metastatic breast cancer patients overexpressing HER-2?}, journal={ANNALS OF ONCOLOGY}, year=2008, pages={1203} }